1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Audentes Therapeutics Inc (BOLD)

  7. Audentes Therapeutics Inc (BOLD) Financials

BOLD

Audentes Therapeutics Inc
59.97
0.00 (0.0%)
Upgrade to Real-Time

Audentes Therapeutics Inc. (BOLD) Fundamentals
Audentes Therapeutics Inc is a biotechnology company. It is engaged in developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects. The company has made some products such as AT132, AT342, AT982 & AT307. Its manufacturing facility is in South San Francisco. The company has established a robust in-house process and analytical development operations for quality purpose.
SHARE INFORMATION
Market CapUS$ 2,750,103,600
Shares Outstanding45,857,989
Float42,888,403
Percent Float93.52%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -3.39
Latest Fiscal Date2018-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions354
Institutional Holdings Date2019-12-31
Institutional Bought Previous 3 Months3,510,032
Institutional Holdings Percent0.0%
Institutional Sold Previous 3 Months6,779,232
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned715,927
TRADING INFO
52 Week HighUS$ 60.00
52 Week LowUS$ 25.04
52 Week High ChangeUS$ 130.74
21 Day Moving AverageUS$ 59.97
21 Day Extended Moving AverageUS$ 59.7517
50 Day Moving AverageUS$ 59.8309
50 Day Extended Moving AverageUS$ 56.1342
200 Day Moving AverageUS$ 40.2705
200 Day Extended Moving AverageUS$ 43.2522
10 Day Average Volume-
20 Day Average Volume-
30 Day Average Volume172,597
50 Day Average Volume662,445
Alpha0.028358
Beta2.1948
Standard Deviation0.209459
R20.119599
7 Day Price ChangeUS$ 0.00
7 Day Percent Change0.0%
21 Day Price ChangeUS$ 0.00
21 Day Percent Change0.0%
30 Day Price ChangeUS$ 0.00
30 Day Percent Change0.0%
Month to Date Price ChangeUS$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price ChangeUS$ 0.13
Quarter to Date Percent Change0.22%
180 Day Price ChangeUS$ 26.22
180 Day Percent Change77.69%
200 Day Price ChangeUS$ 22.12
200 Day Percent Change58.44%
Year to Date Price ChangeUS$ 0.13
Year to Date Percent Change0.22%

Audentes Therapeutics Inc. (BOLD) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book7.40
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio12.80
Leverage Ratio1.10
Quick Ratio12.60
Long Term Debt To Capital0.06
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 2,428,528,600
Price to Sales0.00
Price to Free Cash-21.30
PE High Last 5 Years0.00
Price To Book7.20
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book7.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-46.29
Return on Equity-52.02
Return on Capital-46.56

Audentes Therapeutics Inc. (BOLD) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEONatalie C. Holles
Emplyoees207
Last AuditUQ
CIK0001628738
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address600 California Street
17th Floor
San Francisc, CA 94108
Websitehttp://www.audentestx.com
Facsimile-
Telephone+1 415 818-1001
Emailir@audentestx.com
Your Recent History
NASDAQ
BOLD
Audentes T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230401 09:55:16